Updates in gynecologic care for individuals with lynch syndrome
Lynch syndrome is an autosomal dominant hereditary cancer syndrome caused by germline pathogenic variants (PVs) in DNA mismatch repair genes (MLH1, MSH2, PMS2, MSH6) or the EPCAM gene. It is estimated to affect 1 in 300 individuals and confers a lifetime risk of cancer of 10-90%, depending on the sp...
Main Authors: | Kaylee A. Underkofler, Kari L. Ring |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1127683/full |
Similar Items
-
Screening and prevention of gynecologic malignancies in patients with lynch syndrome: following the guidelines
by: Chen Ben David, et al.
Published: (2025-03-01) -
Endometrial Cancer Diagnosed at an Early Stage during Lynch Syndrome Surveillance: A Case Report
by: Maki Umemiya, et al.
Published: (2023-08-01) -
Editorial: Methods in gynecological oncology
by: Federica Perelli, et al.
Published: (2023-03-01) -
Fertility preservation in patients with gynecological cancer - is it possible?
by: Zrinka Rendić-Miočević, et al.
Published: (2022-01-01) -
Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis
by: Basilio Pecorino, et al.
Published: (2022-11-01)